Fmr LLC Cytokinetics Inc Transaction History
Fmr LLC
- $1.81 Trillion
- Q3 2025
A detailed history of Fmr LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Fmr LLC holds 13,091,647 shares of CYTK stock, worth $870 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,091,647
Previous 11,267,511
16.19%
Holding current value
$870 Million
Previous $372 Million
93.27%
% of portfolio
0.04%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding CYTK
# of Institutions
449Shares Held
129MCall Options Held
5.25MPut Options Held
1.18M-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.1MShares$1.27 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$975 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$788 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.41MShares$492 Million0.07% of portfolio
-
State Street Corp Boston, MA5.62MShares$373 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $6.25B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...